Showing results (1-10 of 1,151) with videos related to
Sort By:
Pageof 116
Journal of Immunology (Baltimore, Md. : 1950)|August 15, 1987
Cobra venom factor and human C3 share carbohydrate antigenic determinantsA H Grier, M Schultz, C W VogelMolecular Immunology|June 1, 1989
The oligosaccharide chains of cobra venom factor are required for complement activationA H Grier, C W VogelMolecular Immunology|March 1, 1992
Structure of the major oligosaccharide of cobra venom factorD C Gowda, M Schultz, R Bredehorst, et al.Tropenmedizin Und Parasitologie|September 1, 1975
Spectrofluorometric and spectrodensitometric determination of chloroquine in plasma and urineC W Vogel, E KönigkExperimental and Clinical Immunogenetics|January 1, 1990
Polymorphism in human T cell receptor alpha chain variable region genesA H Grier, M P Mitchell, M A RobinsonJournal of Immunological Methods|October 12, 1984
Cobra venom factor: improved method for purification and biochemical characterizationC W Vogel, H J Müller-EberhardProceedings of the National Academy of Sciences of the United States of America|December 1, 1981
Induction of immune cytolysis: tumor-cell killing by complement is initiated by covalent complex of monoclonal antibody and stable C3/C5 convertaseC W Vogel, H J Müller-EberhardProceedings of the National Academy of Sciences of the United States of America|December 1, 1986
Immobilized doxorubicin increases the complement susceptibility of human melanoma cells by protecting complement component C3b against inactivationM Panneerselvam, R Bredehorst, C W VogelCancer Research|September 1, 1987
Resistance of human melanoma cells against the cytotoxic and complement-enhancing activities of doxorubicinM Panneerselvam, R Bredehorst, C W VogelThe Journal of Biological Chemistry|February 15, 1987
Doxorubicin enhances complement susceptibility of human melanoma cells by extracellular oxygen radical formationR Bredehorst, M Panneerselvam, C W VogelPageof 116